DNA methylation profile of inflammatory breast cancer and its impact on prognosis and outcome

Flavia Lima Costa Faldoni, Daniela Bizinelli, Cristiano Pádua Souza, Iara Viana Vidigal Santana, Márcia Maria Chiquitelli Marques, Claudia Aparecida Rainho, Fabio Albuquerque Marchi, Silvia Regina Rogatto*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

16 Downloads (Pure)

Abstract

Background: Inflammatory breast cancer (IBC) is a rare disease characterized by rapid progression, early metastasis, and a high mortality rate. Methods: Genome-wide DNA methylation analysis (EPIC BeadChip platform, Illumina) and somatic gene variants (105 cancer-related genes) were performed in 24 IBCs selected from a cohort of 140 cases. Results: We identified 46,908 DMPs (differentially methylated positions) (66% hypomethylated); CpG islands were predominantly hypermethylated (39.9%). Unsupervised clustering analysis revealed three clusters of DMPs characterized by an enrichment of specific gene mutations and hormone receptor status. The comparison among DNA methylation findings and external datasets (TCGA-BRCA stages III-IV) resulted in 385 shared DMPs mapped in 333 genes (264 hypermethylated). 151 DMPs were associated with 110 genes previously detected as differentially expressed in IBC (GSE45581), and 68 DMPs were negatively correlated with gene expression. We also identified 4369 DMRs (differentially methylated regions) mapped on known genes (2392 hypomethylated). BCAT1, CXCL12, and TBX15 loci were selected and evaluated by bisulfite pyrosequencing in 31 IBC samples. BCAT1 and TBX15 had higher methylation levels in triple-negative compared to non-triple-negative, while CXCL12 had lower methylation levels in triple-negative than non-triple-negative IBC cases. TBX15 methylation level was associated with obesity. Conclusions: Our findings revealed a heterogeneous DNA methylation profile with potentially functional DMPs and DMRs. The DNA methylation data provided valuable insights for prognostic stratification and therapy selection to improve patient outcomes. Graphical Abstract: (Figure presented.)

Original languageEnglish
Article number89
JournalClinical Epigenetics
Volume16
Number of pages15
ISSN1868-7075
DOIs
Publication statusPublished - 6. Jul 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

Keywords

  • Biomarker
  • Differentially methylated sites
  • DNA methylation, epigenetic regulation
  • Driver mutations
  • Gene expression
  • Prognosis
  • Humans
  • Middle Aged
  • CpG Islands/genetics
  • DNA Methylation/genetics
  • Biomarkers, Tumor/genetics
  • Inflammatory Breast Neoplasms/genetics
  • Female
  • Adult
  • Aged
  • Gene Expression Regulation, Neoplastic/genetics
  • Epigenesis, Genetic/genetics

Fingerprint

Dive into the research topics of 'DNA methylation profile of inflammatory breast cancer and its impact on prognosis and outcome'. Together they form a unique fingerprint.

Cite this